Chengdu Easton Biopharmaceuticals Co Ltd
医疗健康 · 生物科技
Chengdu Easton Biopharmaceuticals Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, and commercialization of pharmaceutical products in China and internationally. The company offers active pharmaceutical ingredients; finished dosage forms, including capsules, tablets, and injections; pharmaceutical intermediates; biological drugs; and generic drugs. Its products are used in oncology, cardiovascular, neurology and psychiatry, anesthetic and analgesics, urinary, anti-inflammatory, anti-diabetes, anthelmintic, and antiemetic therapeutic categories. The company was founded in 2009 and is headquartered in Chengdu, China.
MARKET 市值 9.86B CNY PE 35.4x
52W ¥38.71 – ¥79.67
EODHD · Q 2026-03-31 · 同步 2026-07-12
QUALITY PEG — 营收 YoY 6.7%
▲ ROE 8.8% 营业利润率 12.4% 净利润率 20.3%
ANALYST 股息率 0.95%